retatrutide clinical trial results 2024 2025 press release Lilly, with new data, to seek FDA approval of obesity drug Retatrutide (LY-3437943) Market Analysis, 2033:
Pay in 4 interest-free payments of $7.12 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23




























